Nicotine dependence and psychiatric disorders
- PMID: 15011738
Nicotine dependence and psychiatric disorders
Abstract
Nicotine addiction is the single largest preventable cause of morbidity and mortality in the Western World. Smoking is not any more just a bad habit, but a substance addiction problem. The pharmacological aspects of nicotine show that this substance has a broad distribution in the different body compartnents, due mainly to its lipophilic characteristic. There are nicotinic receptors as members of cholinergic receptors' family. They are located in neuromuscular junction and in the central nervous system (CNS). Although they are similar, pentameric structure with an ionic channel to sodium, there are some differences in the protein chains characteristics. Repeated administration of nicotine in rats, results in the sensitization phenomenon, which produces increase in the behavioral locomotor activity response. It has been found that most psychostimulants-induced behavioral sensitization through a nicotine receptor activation. Nicotine receptors in CNS are located mainly in presynaptic membrane and in that way they regulated the release of several neurotransmitters, among them acetylcholine, dopamine, serotonin, and norepinephrine. In some activities like sleep-wake cycle, nicotine receptors have a functional significance. Nicotine receptor stimulation promotes wake time, reduces both, total sleep time and rapid eye movement sleep (REMS). About nicotine dependence, this substance full fills all the criteria for dependence and withdrawal syndrome. There are some people that have more vulnerability for to become nicotine dependent, those are psychiatric patients. Among them schizophrenia, major depression, anxiety disorders and attention deficit disorder, represent the best example in this area. Nicotine may have some beneficial effects, among them are some neuroprotective effects in disorders like Parkinson's disease, and Gilles de la Tourette' syndrome. Also there are several evidences that support the role of nicotine in cognitive improvement functions like attention, concentration, and memory. Finally there are several strategies to deal with nicotine dependence, Nicotine Replacement Therapy (NRT), which are nicotine chewing-gum, transdermal nicotine patches, and nicotine inhalators device. Also some antidepressants like bupropion has shown to be effective in smoking cessation treatment. To know more about nicotine phenomenon would be important, because that will allow a more mature perspective about the damage and beneficial effects of that substance.
Similar articles
-
Nicotine dependence: the role for antidepressants and anxiolytics.Curr Opin Investig Drugs. 2002 Feb;3(2):262-71. Curr Opin Investig Drugs. 2002. PMID: 12020058 Review.
-
Non-nicotine pharmacotherapies for nicotine dependence.Essent Psychopharmacol. 2005;6(3):158-72. Essent Psychopharmacol. 2005. PMID: 15869023 Review.
-
Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.Mutat Res. 2009 Jul 10;667(1-2):44-57. doi: 10.1016/j.mrfmmm.2008.10.015. Epub 2008 Nov 5. Mutat Res. 2009. PMID: 19028511 Review.
-
[Depression, tobacco dependence and nicotine].Arch Inst Pasteur Tunis. 2002;79(1-4):65-72. Arch Inst Pasteur Tunis. 2002. PMID: 15072247 French.
-
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].Przegl Lek. 2008;65(10):700-5. Przegl Lek. 2008. PMID: 19189582 Review. Polish.
Cited by
-
Clinical features and therapeutic management of patients admitted to Italian acute hospital psychiatric units: the PERSEO (psychiatric emergency study and epidemiology) survey.Ann Gen Psychiatry. 2007 Nov 5;6:29. doi: 10.1186/1744-859X-6-29. Ann Gen Psychiatry. 2007. PMID: 17983468 Free PMC article.
-
Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments.Psychopharmacology (Berl). 2016 Sep;233(18):3297-314. doi: 10.1007/s00213-016-4362-2. Epub 2016 Jul 6. Psychopharmacology (Berl). 2016. PMID: 27385416
-
Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice.Neuropharmacology. 2007 Apr;52(5):1256-62. doi: 10.1016/j.neuropharm.2007.01.006. Epub 2007 Jan 20. Neuropharmacology. 2007. PMID: 17320916 Free PMC article.
-
Nicotine exposure during adolescence: cognitive performance and brain gene expression in adult heterozygous reeler mice.Psychopharmacology (Berl). 2014 Apr;231(8):1775-87. doi: 10.1007/s00213-013-3388-y. Epub 2013 Dec 13. Psychopharmacology (Berl). 2014. PMID: 24337025
-
Biological basis for the co-morbidity between smoking and mood disorders.J Dual Diagn. 2009;5(2):122-130. doi: 10.1080/15504260902869964. J Dual Diagn. 2009. PMID: 20046987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials